Nemucore Medical Innovations, Inc.

Eli Lilly & Co. said on May 14 that it will pay $110m up front to buy AurKa Pharma Inc. in a deal that will bring the Aurora kinase inhibitor AK-01 back home to Lilly, which licensed the molecule t

Start-Up Execs Armo BioSciences Inc. Gail L. Brown, MD To: CMO (April) From: Senior Medical Dir., AbbVie Inc. Phone: 650-779-5075 Atreca Inc. Norman M. Greenberg, PhD To: CSO (May) From:

Start-Up Execs Auspherix Ltd. Neil Miller, PhD To: CSO (December) From: Senior Dir., Head, Chemistry, DMPK & External Discovery, Singapore Phone: +44 1438 906755 Delphinus Medical Technologie

IN VITRO DIAGNOSTICS AltheaDx Inc. AltheaDx 's Series C brings in $30mm AltheaDx Inc. (oncology R&D services and personalized medicine focused on cardio, neuro, and blood disorders) brought in